1-4 of 4
Anthony Tolcher, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Trial Results from the Subgroup of Lymphoma/CLL in a Phase 1 Study of ARQ 092, a Novel Pan AKT-Inhibitor

Wael Harb, Mansoor N. Saleh, MD, Kyriakos P Papadopoulos, MD, Feng Chai, MD, Maria Larmar, Giovanni Abbadessa, MD, Brian Schwartz, MD, Anthony Tolcher, MD
Journal: Blood
Blood (2015) 126 (23): 5116.
https://doi.org/10.1182/blood.V126.23.5116.5116
Published: 2015
Journal Articles

Establishment and Characterization of a Patient-Derived Model of ALK-Positive Anaplastic Large Cell Lymphoma

Michael J Wick, PhD, Elena Helman, PhD, Teresa L Vaught, DVM, Monica Farley, BS, Drew W Rasco, MD, Lon Smith, MD, Anthony Tolcher, MD, Amita Patnaik, MD, Michael Clark, PhD, Kyriakos P Papadopoulos, MD
Journal: Blood
Blood (2015) 126 (23): 5121.
https://doi.org/10.1182/blood.V126.23.5121.5121
Published: 2015
Journal Articles

ASN002: A Potent Dual SYK/JAK Inhibitor Currently in a Phase I/II Study Shows Strong Antitumor Activity in Preclinical Studies

Niranjan S. Rao, PhD, Sanjeeva Reddy, PhD, Gupta Sandeep, PhD, Nitin K Damle, PhD, Venkatesan M Aranapakam, PhD, Scott Thompson, PhD, Roger Smith, PhD, Terry Plasse, MD, Penelope Bristow, MS, Anthony Tolcher, MD, Kyriakos P Papadopoulos, MD, Amita Patnaik, MD, Drew W Rasco, MD
Journal: Blood
Blood (2015) 126 (23): 4009.
https://doi.org/10.1182/blood.V126.23.4009.4009
Published: 2015
Journal Articles

Efficacy and Safety of YM155 in Relapsed/Refractory Non-Hodgkin’s Lymphoma Patients Enrolled in a Phase I Study.

Kyriakos Papadopoulos, MD, Alain Mita, MD, Scott Antonio, MD, Lionel D. Lewis, MD, N.J. Reddy, Elizabeth Till, J.J. Mahany, Anne Keating, DPharm, Amanda Seiz, Pamela Bartels, Anthony Tolcher, MD
Journal: Blood
Blood (2007) 110 (11): 3422.
https://doi.org/10.1182/blood.V110.11.3422.3422
Published: 2007